Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (22)

2024

  1. An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer

    Molecular Cancer, Vol. 23, Núm. 1

  2. Radiotherapy protocols for mouse cancer model

    Methods in Cell Biology (Academic Press Inc.), pp. 99-113

2023

  1. Flow cytometry-assisted quantification of immune cells infiltrating irradiated tumors in mice

    Methods in Cell Biology, Vol. 174, pp. 1-16

  2. Methods to assess radiation induced abscopal responses in mice

    Methods in Cell Biology (Academic Press Inc.), pp. 81-92

  3. The Lymphatic Endothelium in the Context of Radioimmuno-Oncology

    Cancers, Vol. 15, Núm. 1

2022

  1. Assessment of hypoxia by pimonidazole staining following radiotherapy

    Methods in Cell Biology (Academic Press Inc.), pp. 179-189

  2. Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer

    Cancer Discovery, Vol. 12, Núm. 5, pp. 1356-1377

2021

  1. Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Núm. 26

2020

  1. Immunological impact of cell death signaling driven by radiation on the tumor microenvironment

    Nature Immunology, Vol. 21, Núm. 2, pp. 120-134

  2. Monitoring abscopal responses to radiation in mice

    Methods in Enzymology (Academic Press Inc.), pp. 111-125

2019

  1. Immune mechanisms mediating abscopal effects in radioimmunotherapy

    Pharmacology and Therapeutics, Vol. 196, pp. 195-203

  2. Time for radioimmunotherapy: an overview to bring improvements in clinical practice

    Clinical and Translational Oncology, Vol. 21, Núm. 8, pp. 992-1004

2018

  1. Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect

    Trends in Immunology, Vol. 39, Núm. 8, pp. 644-655

  2. Intratumoral immunotherapy with XCL1 and sFlt3L encoded in recombinant semliki forest virus–derived vectors fosters dendritic cell–mediated t-cell cross-priming

    Cancer Research, Vol. 78, Núm. 23, pp. 6643-6654

2017

  1. Brachytherapy attains abscopal effects when combined with immunostimulatory monoclonal antibodies

    Brachytherapy, Vol. 16, Núm. 6, pp. 1246-1251

  2. Interleukin-8 in cancer pathogenesis, treatment and follow-up

    Cancer Treatment Reviews, Vol. 60, pp. 24-31

  3. Strategies to design clinical studies to identify predictive biomarkers in cancer research

    Cancer Treatment Reviews, Vol. 53, pp. 79-97

2015

  1. Functional expression of CD137 (4-1BB) on T helper follicular cells

    OncoImmunology, Vol. 4, Núm. 12

  2. Pneumomediastinum as a complication of SABR for lung metastases

    Radiation Oncology, Vol. 10, Núm. 1

2014

  1. A proposal for the stratification of the risk of locoregional failure after surgical resection, perioperative high dose rate brachytherapy, and external beam irradiation: The University of Navarre predictive model

    Brachytherapy, Vol. 13, Núm. 4, pp. 400-404